Neurofibromatosis type 1
- Recklinghausen's disease
- Type 1 neurofibromatosis
- Von Recklinghausen disease
News & Events
ORDR Co-Sponsored Conferences
4th International RASopathies Symposium, Friday, July 17, 2015 - Sunday, July 19, 2015
Location: Doubletree by Hilton at SeaTac, Seattle, WA
Description: This symposium will provide a venue for a scientific conversation between clinicians, researchers, trainees and affected families to share and discuss clinical issues and basic science and set forth a framework for future research, translational applications directed towards therapy, and best clinical practices for RAS/MAPK pathway syndromes.
Children's Tumor Foundation 2014 Neurofibromatosis (NF) Conference, Saturday, June 07, 2014 - Tuesday, June 10, 2014
Location: Washington , D.C.
Description: In order to stimulate exchange between basic scientists and clinical investigators, a number of sessions will be organized to discuss preclinical models and findings side by side with clinical findings and current management in patients. The hope is that this exchange will promote the translation of preclinical findings into clinical trials. Moreover, invited speakers outside of the NF community will add to the scientific diversity and stimulate discussions and promote new collaborations.
International Meeting on Genetic Syndromes of the Ras/MAPK Pathway, Friday, July 29, 2011 - Sunday, July 31, 2011
Location: The Westin O’Hare, Chicago, IL
Description: The ultimate goals of this meeting are to develop better medical management and establish novel therapies. The overall goal is to provide a forum for researchers, clinicians, physician-scientists, trainees, and affected persons/families to share and discuss basic science and clinical issues in order to set forth a solid framework for future research, translational applications directed toward therapy, and best practices for individuals with Ras/MAPK pathway syndromes.
Genetic Syndromes of the Ras/MAPK Pathway: From Bedside to Bench and Back, Saturday, August 01, 2009 - Sunday, August 02, 2009
Location: DoubleTree Hotel and Executive Meeting Center at the Berkeley Marina, Berkeley, CA
Description: The overall goal of this symposium was to provide an open forum for researchers, clinicians and physician–scientists, trainees, and families to share and discuss basic science and clinical issues to set forth a solid framework for future research, translational applications directed toward therapy, and best practices for individuals with these syndromes. Formalization of basic science and clinical research through this symposium would also provide insight into the cause and progression of cancer as well as the understanding of how this critical signal transduction pathway is involved in the regulation of normal human development.
Workshop on Phacomatoses Revisited (Neurofibromatosis 1 and 2, Tuberous Sclerosis 1 and 2 [TSC1, 2], von Hippel-Lindau syndrome [VHL], Gorlin syndrome [PTCh], Cowden's disease [PTEN], Familial Adenomatous Polyposis [APC]), Wednesday, March 03, 1999
- Neurofibromatoses and RASopathies: Their Management, Diagnosis, Current and Future Therapeutic Avenues
Monday, September 30, 2013 - Tuesday, October 01, 2013
Location: Radisson Blu Hotel, Cardiff, Wales
Description: This international meeting will provide a most comprehensive and up to date account of recent developments in this field. Internationally recognized experts from the UK, Europe and the USA will speak on neurofibromatoses and rasopathies. This meeting will be suitable for medical geneticists, oncologists, dermatologists, neurologists, endocrinologists, psychiatrists, molecular and cellular biologists, genetic counsellors and general practitioners.